Root, Inc. Income Taxes Disclosure
For the Years Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| (dollars in millions) | |||||||||||||||||
| Current: | |||||||||||||||||
| Federal | $ | — | $ | — | $ | — | |||||||||||
| State | 0.5 | — | — | ||||||||||||||
| Foreign | — | — | — | ||||||||||||||
| Total current | 0.5 | — | — | ||||||||||||||
| Deferred: | |||||||||||||||||
| Federal | — | — | — | ||||||||||||||
| State | — | — | — | ||||||||||||||
| Foreign | — | — | — | ||||||||||||||
| Total deferred | — | — | — | ||||||||||||||
Total income tax expense | $ | 0.5 | $ | — | $ | — | |||||||||||
| 2025 | |||||||||||
| (dollars in millions) | |||||||||||
Income (loss) before income taxes | |||||||||||
Domestic | $ | (59.5) | |||||||||
Foreign | 100.3 | ||||||||||
| Income before income taxes | $ | 40.8 | |||||||||
| Statutory United States federal income tax expense | $ | 8.6 | 21.0 | % | |||||||
State and local income tax expense, net of federal income tax effect(1) | 0.4 | 1.0 | |||||||||
| Foreign tax effects - Cayman Islands | |||||||||||
| Foreign rate differential | (21.2) | (52.0) | |||||||||
| Effect of cross-border tax laws | |||||||||||
| United States tax on foreign insurance income | 21.2 | 52.0 | |||||||||
| Valuation allowance on deferred tax assets | (12.6) | (30.9) | |||||||||
| Nontaxable and nondeductible items | |||||||||||
| Share-based compensation | (11.8) | (28.9) | |||||||||
| Nondeductible warrant expense | 9.3 | 22.8 | |||||||||
| Nondeductible compensation | 5.8 | 14.2 | |||||||||
| Other nondeductible expenses | 0.2 | 0.5 | |||||||||
| Other adjustments | 0.6 | 1.5 | |||||||||
| Income tax expense | $ | 0.5 | 1.2 | % | |||||||
| 2024 | 2023 | ||||||||||||||||||||||
| (dollars in millions) | |||||||||||||||||||||||
| Income (loss) before income taxes | $ | 30.9 | $ | (147.4) | |||||||||||||||||||
Statutory United States federal income tax expense (benefit) | 6.5 | 21.0 | % | (30.9) | 21.0 | % | |||||||||||||||||
| Valuation allowance on deferred tax assets | (10.5) | (34.0) | 34.9 | (23.7) | |||||||||||||||||||
| Share-based compensation | (6.0) | (19.4) | 5.5 | (3.7) | |||||||||||||||||||
| Nondeductible compensation | 2.9 | 9.4 | 1.2 | (0.8) | |||||||||||||||||||
| Return to provision permanent adjustments | — | — | — | — | |||||||||||||||||||
| State net operating loss | 7.9 | 25.6 | (10.5) | 7.1 | |||||||||||||||||||
| Other | (0.8) | (2.6) | (0.2) | 0.1 | |||||||||||||||||||
Income tax expense | $ | — | — | % | $ | — | — | % | |||||||||||||||
| 2025 | 2024 | ||||||||||
| (dollars in millions) | |||||||||||
| Deferred tax assets: | |||||||||||
| Unpaid losses and loss adjustment expenses | $ | 4.2 | $ | 3.3 | |||||||
| Unearned premium reserves | 16.4 | 14.2 | |||||||||
| Disallowed interest carryforward | 10.4 | 20.8 | |||||||||
| Deferred compensation | 5.2 | 8.2 | |||||||||
| Stock and warrant compensation | 12.6 | 12.0 | |||||||||
| Other | 6.0 | 5.1 | |||||||||
| State net operating loss carryforward | 28.0 | 20.0 | |||||||||
Federal net operating loss carryforward | 269.8 | 271.6 | |||||||||
| Gross deferred assets | 352.6 | 355.2 | |||||||||
| Less valuation allowance | (339.8) | (345.9) | |||||||||
| Total deferred tax assets, less valuation allowance | 12.8 | 9.3 | |||||||||
| Deferred tax liabilities: | |||||||||||
Research and experimental expenditures | — | 0.2 | |||||||||
| Fixed assets | 0.3 | 0.4 | |||||||||
Deferred policy acquisition costs | 9.9 | 6.7 | |||||||||
Intangible assets | 0.7 | 0.6 | |||||||||
Investments | 0.9 | 0.9 | |||||||||
| Other | 1.0 | 0.5 | |||||||||
| Deferred tax liabilities | 12.8 | 9.3 | |||||||||
| Net deferred tax asset | $ | — | $ | — | |||||||
| Carryforward with Expiration | Carryforward Indefinitely | Total | Years of Expiration | ||||||||||||||||||||
| (dollars in millions) | |||||||||||||||||||||||
| Federal | $ | 629.6 | $ | 655.1 | $ | 1,284.7 | 2038-2046 | ||||||||||||||||
| State and local (gross, apportioned) | 232.1 | 255.2 | 487.3 | 2026-2045 | |||||||||||||||||||
| Research and development credits | 0.9 | — | 0.9 | 2036-2038 | |||||||||||||||||||
| Total | $ | 862.6 | $ | 910.3 | $ | 1,772.9 | |||||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 25, 2026 | Showing above |
| 2024 | Feb 26, 2025 | |
| 2023 | Feb 21, 2024 | |
| 2022 | Feb 22, 2023 | |
| 2021 | Feb 23, 2022 | |
| 2020 | Mar 4, 2021 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.